Track the BioArctic AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, BioArctic AB has published 4 public disclosures. Market capitalisation: €27.7bn. The latest transaction was filed on 19 December 2025 (Sale). Among the most active insiders: Pär Gellerfors. All data is openly available.
4
Insider Decl.
0
Thresholds
€10,308
2 ops.
Buy Volume
€10m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate BioArctic AB Hold (neutral), based on 5 analysts. Average price target: SEK 301.40.
32Σ signal
Buys €10,308€10m Sells
Fundamental score
Ranked 4,793 of 25,921 companies
67.8
score / 100
Value
47
Quality
88
FCF yld5.1%
Earn yld3.7%
EV/EBITDA22.0x
ROE10%
Gross mgn97%
Net mgn51%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.